News

Researchers discover a fungal protein that plays a key role in causing disease in plants and animals and which also shields the pathogen from oxidative stress.

Transaction adds to QIAGEN’s content engine for development of future diagnostics and boosts the Company’s presence in pharma discovery and validation.

Locus has created a new division, Ansaris, which will include most of its operations and personnel.

There is a new web-accessible compound database called Chemonaut which is comprised of >5M available leadlike molecules and fragments for screening.

Aureus will provide new AurSCOPE® knowledge databases and continue to update existing databases for sanofi-aventis' R&D division.

New end-to-end solution expected to impact researchers’ ability to aggregate raw data across Next Generation Sequencing experiments to get results faster.

Thanks to scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, it is now possible to accurately predict when and where different CRMs will be active. The study, published today in Nature, is a first step towards forecasting the expression of all genes in a given organism and demonstrates that the genetic regulation that is crucial for correct embryonic development is more flexible than previously thought.

With SAS OnDemand, DSPA will have a globally accessible, fully regulatory compliant repository for all of its clinical data.

Contract will support expanded rollout of Phase Forward’s WebSDM product with clinical trials signal detection at FDA CDER.

Roche and Fluofarma will work together to develop a hepatotoxicity prediction tool based on HCS that may lead to future increased synergies.